Sign in

CIK 0001851484 · <br>Emerging growth company

CITIUS ONCOLOGY, INC.

Sign in to watch
Ticker
CTOR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
994362660
Phone
(908) 967-6677
Business address
11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
Former names
TenX Keane Acquisition
  1. ARS Other Annual Report to Security Holders
  2. EFFECT Other Notice of Effectiveness
  3. DEF 14C Other DEF 14C
  4. PRE 14C Other PRE 14C
  5. EFFECT Other Notice of Effectiveness
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. DEF 14C Other DEF 14C
  8. PRE 14C Other PRE 14C
  9. EFFECT Other Notice of Effectiveness
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. EFFECT Other Notice of Effectiveness
  12. DRS Other Draft Registration Statement
  13. EFFECT Other Notice of Effectiveness
  14. DRS Other Draft Registration Statement
  15. DEFA14C Other DEFA14C
  16. DEF 14C Other DEF 14C
  17. PRE 14C Other PRE 14C
  18. 25-NSE Other Notification of Removal from Listing
  19. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  20. EFFECT Other Notice of Effectiveness

Page 1 of 2 · 30 filings